BlackRock Fund Advisors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

BlackRock Fund Advisors’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8.98M	Buy	90,432 +13,236	+17%	+$1.39M	﹤0.01%	2633
2016 Q3	$8.65M	Buy	77,196 +5,415	+8%	+$650K	﹤0.01%	2553
2016 Q2	$7.37M	Buy	71,781 +29,363	+69%	+$2.94M	﹤0.01%	2588
2016 Q1	$3.9M	Sell	42,418 -1,075	-2%	-$115K	﹤0.01%	2867
2015 Q4	$6.27M	Buy	43,493 +1,265	+3%	+$165K	﹤0.01%	2711
2015 Q3	$4.37M	Buy	+42,228	New	+$4.95M	﹤0.01%	2867

Other funds holding SIOX

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock Fund Advisors's SIOX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Sio Gene Therapies Inc. Common Stock (SIOX) stake by 17% in Q4 2016, buying an estimated $1.39M and bringing the position to 90,432 shares worth $8.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

BlackRock Fund Advisors first reported a position in SIOX in Q3 2015 and has held it in 6 quarters since. 101 funds tracked by Wall St. Rank hold SIOX as of Q4 2016.

BlackRock Fund Advisors held 90,432 shares of Sio Gene Therapies Inc. Common Stock worth $8.98M as of Q4 2016.
BlackRock Fund Advisors bought 13,236 Sio Gene Therapies Inc. Common Stock shares in Q4 2016, an estimated $1.39M.
Sio Gene Therapies Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2633 holding.
BlackRock Fund Advisors first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and has held it in 6 quarters since.
101 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.